Foxconn, Aurora Advocate to collect data from 13K employees to streamline care delivery

Foxconn made headlines when it announced plans to build a $10 billion plant in Racine County, Wisconsin. Now, the Taiwanese tech giant has sights set on improving healthcare for the 13,000 employees who will work at the facility.

Foxconn announced a joint initiative with Advocate Aurora Health, which is a new company that resulted from a merger of Illinois-based Advocate Health Care with Milwaukee’s Aurora Health Care.

"Technology will play a critical role in the future of health and wellness," Nick Turkal, MD, Advocate Aurora Health president and CEO, said in a statement. "We are excited about what we can do together to benefit not only our patients and communities here locally, but how our combined capabilities could potentially have a positive impact on wellness globally."

Foxconn hopes to leverage predictive modeling and artificial intelligence to streamline preventative care and employee wellness programs. The company will work with Advocate Aurora to collect and analyze health data from the workers in Wisconsin.

Rick Klein, with Advocate Aurora Health, said that data can be used in support from its staff, clinics and hospitals.

"What's really different than what happens today is that somebody may have a Fitbit app or they may belong to a health club, or whatever it happens to be, but that information isn't organized at the same time that they need it when they go see the physician," Klein said, explaining what’s called a "smart city" concept

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup